About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Genetic Testing for BRCA Gene Mutations on the Rise in Young Women

by Shirley Johanna on February 12, 2016 at 6:36 PM
Font : A-A+

Genetic Testing for BRCA Gene Mutations on the Rise in Young Women

The rates of genetic testing for BRCA1 and BRCA2 mutations have increased among women diagnosed with breast cancer at age 40 or younger, says a new study.

Breast cancer is the most common cancer diagnosed in women younger than 40. Women who are carriers of BRCA1 and BRCA2 gene mutations are at increased risk for developing breast cancer. The National Comprehensive Cancer Network guidelines recommends women diagnosed with breast cancer at 50 or younger to be tested for the gene testing.

Advertisement


Dr Ann H. Partridge of the Dana-Farber Cancer Institute, Boston, and coauthors described the use of BRCA testing in a group of women diagnosed with breast cancer at 40 or younger and examined how concerns about genetic risk and genetic information affected treatment decisions.

The researchers analyzed 897 women 40 and younger diagnosed with breast cancer at 11 academic and community medical centers.

They found 780 (87%) of women underwent BRCA testing by one year after breast cancer diagnosis (average age at diagnosis 35.3 years vs. 36.9 years for untested women). Only 117 (13%) women had not undergone BRCA testing for a mutation when surveyed one year after diagnosis.
Advertisement

The frequency of testing increased over time. Of 39 women diagnosed with breast cancer in 2006, 30 (76.9%) reported testing; a slightly lower percentage of women reported testing in 2007 (87 of 124 or 70.2%); but the proportion of women tested increased in subsequent years with 141 (96.6%) of 146 women in 2012 and 123 (95.3%) of 129 women diagnosed as having breast cancer in 2013 reporting BRCA testing, according to the results.

Among the 780 women who had undergone the genetic testing, 59 (7.6%) reported a BRCA1 mutation, 35 (4.5%) reported a BRCA2 mutation and 35 (4.6%) reported an indeterminate result or variant of unknown clinical significance.

Among the 117 untested women, 37 (31.6%) did not report discussing the possibility they may have a mutation with their physician or genetic counselor and 43 (36.8%) of the 117 women were thinking of future testing.

Of the 831 participants, 248 (29.8%) reported that knowledge or concern about the genetic risk of breast cancer influenced their treatment in some way. Within that group, 76 of 88 mutation carriers (86.4%) and 82 of 160 noncarriers (51.2%) opted for a bilateral mastectomy to remove both breasts. Those who were carriers of a mutation were more likely to undergo a salpingo-oophorectomy (ovary removal) than noncarriers.

The researchers said that the high frequency of the genetic testing may be attributed to the fact that most women were insured, educated and treated at cancer centers genetic counseling and testing services were widely available.

They also said that that media attention to genetic breast cancer as a result of the Angelina Jolie effect may have also played a role among women to bring up the issue of genetic risk with their physician or genetic counselor.

The researchers also noted that bilateral mastectomy was still relatively common even among noncarriers "suggesting that many women might choose to remove both breasts because of worries about developing another breast cancer and for peace of mind despite knowing they do not carry a known BRCA mutation."

"Given that knowledge and concern about genetic risk influence surgical decisions and may affect systemic therapy trial eligibility, all young women with breast cancer should be counseled and offered genetic testing, consistent with the National Comprehensive Cancer Network guidelines," the study concludes.

The study is published online in the journal JAMA Oncology.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Genetics and Stem Cells Genetic Testing of Diseases Cystic Fibrosis Paternity Testing - Whose Baby Is It Anyway? McArdle Disease Weaver Syndrome Christianson Syndrome Seckel Syndrome Polymerase Chain Reaction 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) A-Z Drug Brands in India Accident and Trauma Care Iron Intake Calculator Calculate Ideal Weight for Infants Turmeric Powder - Health Benefits, Uses & Side Effects Blood Pressure Calculator Drug Interaction Checker Hearing Loss Calculator Daily Calorie Requirements
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Genetic Testing for BRCA Gene Mutations on the Rise in Young Women Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests